Tigermed roars in its Hong Kong stock trading debut, as Asia’s largest health care IPO of 2020 draws traders to its clinical trials

, , Comments Off on Tigermed roars in its Hong Kong stock trading debut, as Asia’s largest health care IPO of 2020 draws traders to its clinical trials

It plans to use much of the US$1.38 billion raised to expand overseas, amid the huge surge in clinical trials for products related to potential vaccines and treatments for the coronavirus.
( read original story …)